Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Paul J. Wang, MD, director of the Stanford Cardiac Arrhythmia service, discusses the development of a new treatment for hard-to-treat AFib.
Known as hybrid surgical-catheter ablation, this new treatment combines catheter ablation with thoracoscopic surgery, a minimally invasive chest surgery, to treat tissue both inside and outside the heart.
CARE AT STANFORD
Our expert doctors and staff offer comprehensive diagnostic tools and advanced treatment for people with heart arrhythmias, including atrial fibrillation.